Research Article
Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea
Table 2
Treatment pattern change by age and the Child–Pugh classification in single lesions.
| Treatment n = 4601 | Age (years) | ≤59 | 60–69 | ≥70 | value |
| Surgical resection | 859 (39.6%) | 390 (28.9%) | 194 (18.0%) | <0.001 | Liver transplantation | 35 (1.6%) | 12 (0.9%) | 0 (0.0%) | <0.001 | Local ablative therapy | 422 (19.4%) | 289 (21.4%) | 200 (18.5%) | 0.784 | Transarterial therapy | 729 (33.6%) | 553 (41.0%) | 518 (48.0%) | <0.001 | Systemic chemotherapy | 7 (0.3%) | 6 (0.4%) | 7 (0.6%) | 0.188 | Radiation therapy | 7 (0.3%) | 12 (0.9%) | 4 (0.4%) | 0.525 | No treatment | 112 (5.2%) | 88 (6.5%) | 157 (14.5%) | <0.001 |
| n = 4601 | Child–Pugh classification | A | B | C | value | Surgical resection | 1390 (36.3%) | 52 (7.9%) | 1 (0.9%) | <0.001 | Liver transplantation | 24 (0.6%) | 10 (1.5%) | 13 (11.5%) | <0.001 | Local ablative therapy | 776 (20.2%) | 116 (17.7%) | 19 (16.8%) | 0.094 | Transarterial therapy | 1405 (36.7%) | 356 (54.4%) | 39 (34.5%) | <0.001 | Systemic chemotherapy | 14 (0.4%) | 6 (0.9%) | 0 (0.0%) | 0.282 | Radiation therapy | 13 (0.3%) | 10 (1.5%) | 0 (0.0%) | 0.010 | No treatment | 211 (5.5%) | 105 (16.0%) | 41 (36.3%) | <0 .001 |
|
|